Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0085584 (
encephalopathy
)
18,178
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The density and size of astrocyte-, oligodendrocyte-and neurone nuclei in corpus striatum were determined in rats with CCl4-induced liver
encephalopathy
by means of an electronic image analyzer. After 8 weeks of CCl4-administration, the astrocyte number had nearly doubled, and astrocytes with increased nuclear size qppeared. After 20 weeks, a reduction (appr. 25 per cent) was found in the number of nerve cells and oligodendrocytes. The total number of glial cells, however, was unchanged during the experiment; this demonstrates the need of performing differential counts when evaluating gliosis. Probably, a part of the increase in the number of astrocytes was due to a transformation from precursor cells, usually classified as oligodendrocytes. The increased number and size of astrocyte nuclei are probably connected with an enhanced astrocyte metabolic capacity due to alterations in the
ammonia
and amino acid metabolism.
...
PMID:Glial and neuronal alteration in the corpus striatum or fats with CCl4--induced liver disease. A quantitative morphological study using an electronic image analyzer. 84 80
We report Reye syndrome in an 11-year-old boy whose first symptoms were generalized convulsions and coma without clinical or laboratory evidence of liver disease. Serum glutamic oxaloacetic transaminase and lactate dehydrogenase (LDH) values increased strikingly on the third day after the onset of coma. These enzymatic changes were associated with prolongation of prothrombin time. A rise in blood
ammonia
concentrations began on the fourth day of coma. The diagnosis of Reye syndrome was confirmed by a liver biopsy and at autopsy. This case demonstrates that
encephalopathy
in Reye syndrome can develop prior to detectable hepatic involvement, and suggests that factors unrelated to generalized liver damage may occasionally play a role in the pathogenesis of this obscure disorder.
...
PMID:Reye syndrome without initial hepatic involvement. 84 16
A case report is given on two patients receiving halothane anesthesia while beeing treated with isoniacid, ethambutol and rifampicin. Following halothane anesthesia, both patients developed a severe liver disease with
encephalopathy
grade III. We observed a moderate increase of bilirubin and SGOT and a more severe increase of serum
ammonia
. Histologically, both patients had alterations compatible with drug hepatitis. Within 14 days remission occurred spontaneously. The two case reports do not fit with typical isoniacid hepatitis or typical halothane hepatitis. The possibility of combined drug toxicity on liver during halothane and isocianid treatment is discussed.
...
PMID:[Halothane and antituberculous drugs--a hepatotoxic combination? (author's transl)]. 90
Between December 15, 1973, and Jun 30, 1974, a total of 379 cases of Reye's syndrome was reported to the Center for Disease Control. One hundred forty-seven (40%) were confirmed by either autopsy or biopsy, while 232 were diagnosed by clinical and laboratory parameters. Comparisons of the epidemiologic and demographic characteristics, the hospital course, the outcome, and the laboratory abnormalities of the clinically diagnosed and the pathologically confirmed cases revealed no significant differences. In the epidemiologic setting of influenza B outbreaks, children who have the acute onset of noninflammatory
encephalopathy
associated with elevated serum transaminase levels, hypoprothrombinemia, and elevated blood
ammonia
levels should be considered to have Reye's syndrome. Further evaluation of diagnostic criteria is needed, however, for sporadically occurring, nonepidemic cases of noninflammatory
encephalopathy
associated with hepatic dysfunction.
...
PMID:Diagnostic criteria for influenza B-associated Reye's syndrome: clinical vs. pathologic criteria. 91 32
Results of a histochemical study of glutamic dehydrogenase in experimental portal-systemic encephalopathy with hyperammonemia indicate that the enzyme's activity in brain was increased in all stages of the
encephalopathy
, and this increase appeared to be localized exclusively in astrocytes. The results are consistent with the view that the astrocyte has a critical role in
ammonia
metabolism in brain, probably in
ammonia
detoxification. The findings, moreover, indicate that one pool of glutamate, possibly the small pool, is located in the astrocyte.
...
PMID:Histochemical studies in experimental portal-systemic encephalopathy. 94 32
Lactulose is a synthetic disaccharide that lowers elevated blood
ammonia
levels and improves symptoms in patients with portosystemic
encephalopathy
. It is generally well tolerated and appears to be a suitable alternative to neomycin sulfate for maintenance therapy to prevent recurrent attacks and to improve protein tolerance.
...
PMID:Lactulose (cephulac) in portosystemic encephalopathy. 98 71
To avoid the dangerous consequences of gastro-intestinal haemorrhages in portal hypertension, portosystemic anastomosis is often performed. These operations unfortunately cause numerous complications among which isolated
encephalopathy
and encephalo-myelopathy hold pride of place. In spite of their different clinical, biological, therapeutic and anatomo-pathological behaviour, these two complications are undoubtedly the result of a common pathogenesis of which the details are not at present understood. It is, however, known that these involve complex metabolic disorders connected with the direct passage into the caval blood of products from the gut (
ammonia
, false neurotransmitters, ...). Experiments with rats have shown development of type II Alzheimer glia in the cerebellum after portocaval anastomosis; so far, spinal lesions have not been reproduced (10-76). In conclusion, it must be recognized that, as Lucien Leger (39) wrote, "by creating a new physiopathology, portal decompression raises as many questions as it solves."
...
PMID:[Porto-systemic encephalo-myelopathy]. 110 50
The effect of total colectomy and "intestinal sterilisation" following chronic portocaval shunt was investigated in 96 Sprague-Dawley rats: while both therapeutic procedures are of no significant impact on serum
ammonia
concentrations there is a significant reduction of brain octopamine, a known false neuro-chemical transmitter, and a clear response on aromatic amino acid levels in brain and plasma. The interference with central and peripheral neurotransmitters is suggested as an alternative mechanism in experimental
encephalopathy
.
...
PMID:[New evaluation of effect of total colectomy and intestinal sterilization following portacaval shunt]. 110 99
Cerebral biopsies were obtained for electron microscopy 48 and 72 hours after the onset of
encephalopathy
from a child with severe Reye's syndrome. Gravely ill at the time of craniectomy to relieve cerebral hypertension, the child survived and recovered good brain function; therefore, the biopsy findings appear to reflect the organelle pathology of the brain at a severe yet reversible stage in the disease process. The cardinal ultrastructural changes in the brain in Reye's syndrome are astrocyte swelling and partial deglycogenation, myelin bleb formation and universal injury of neuron mitochondria. The mitochondrial injury consists of matrix disruption with moderate but not massive swelling. Dilatation of rough endoplasmic reticulum and nuclear changes occurred only in neurons with severely altered mitochondria. The organelle pathology of the brain in this case did not resemble the organelle pathology of the brain in human "hepatic encephalopathy" or in experimental
ammonia
intoxication in primates. The mitochondrial ultrastructure of the cerebral neurons resembled the unique mitochondrial ultrastructural changes seen in the liver parenchyma in Reye's syndrome.
...
PMID:Brain ultrastructure in Reye's syndrome. 117 96
The authors have achieved 5 complete recoveries from coma and two partial recoveries in 9 non-decerebrate patients in coma due to acute hepatic atrophy by using polyacrylonitrile membrane haemodialysis. Survival was not possible until sufficient hepatic regeneration had developed. On the other hand, repeated returns to consciousness were observed with prolonged survival lasting up to 40 days despite almost complete destruction of the liver. The different hypothesis relating to the mechanism of the
encephalopathy
and the usefulness of such a procedure are discussed: filtration of
ammonia
, free fatty-acids, role of amino-acids and possible polypeptides.
...
PMID:[Encephalopathy in acute hepatic atrophy. Effect of the purification of middle molecules. Preliminary results]. 122 52
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>